On December 2, Renfu Pharmaceutical issued an announcement stating that it was concerned about the discussion on fentanyl on the Internet, mentioning the smuggling and abuse of fentanyl substances in the United States and the fact that both China and the United States will pay close attention and take effective measures to deal with the situation.
Renfu Pharmaceutical pointed out that fentanyl citrate injection, sufentanil citrate injection, remifentanil hydrochloride for injection and raw material medicine (synthetic "fentanyl series products") are the company's main products, and the company's holding subsidiary Yichang Renfu Pharmaceutical Co., Ltd. (abbreviated as "Yichang Renfu", the company holds 67% of its equity) Production and sales, the company's fentanyl series products are described as follows:
1, the company's fentanyl series is a strictly controlled narcotic drugs.China's "Drug Administration Law" and "Regulations on the Administration of Hemp Drugs" have made comprehensive and systematic provisions on the management of experimental research, production, operation, use, storage, and transportation of such drugs. Yichang Renfu strictly follows the relevant regulations. Implementation, especially in terms of domestic circulation, implements the purchase and sales process of "fixed-point production enterprises → national wholesale enterprises (qualified) → regional wholesale enterprises (qualified) → medical institutions".
At the same time, the State Drug Administration strictly controls the production, import and export of narcotic drugs and psychotropic substances in China in accordance with the 1988 United Nations Convention against Illicit Traffic in Narcotic Drugs and Psychotropic Substances.In accordance with the relevant provisions, Yichang Renfu formulated the "Special Management Drug Export Sales Management" and "Special Management Drug Delivery Management" and other management procedures, strictly controlled the customer's qualifications and transportation routes, and obtained the import license issued by the official of the importing country, the export license issued by the State Drug Administration, and other materials. In the case of completeness, the customs shall be declared according to the procedures stipulated by law to export and sell products.
2. In 2017, the sales revenue of Yichang Renfu Fentanyl series products exceeded RMB 2 billion; among them, the export sales revenue was approximately RMB 5 million, which was mainly exported to Sri Lanka, Ecuador, the Philippines, Turkey and other countries or regions, and the purchasers were all national official procurement agencies of the importing countries, local officially recognized companies with regulatory pharmaceutical business qualifications, or local factories with regulatory pharmaceutical production qualifications.As of now, Yichang Renfu has not exported any fentanyl substances (intermediates, raw materials or preparations) to the United States.
Renfu Medicine pointed out that the company strictly abides by the laws and regulations of the State on narcotic drugs, actively supports the strict control of narcotic drugs in various countries and regions of the world, and always adheres to the principle of "corporate citizenship" and strives to create a harmonious society environment.